Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does sevelamer have anti-atherosclerotic properties in maintenance hemodialysis patients?

Nature Clinical Practice Nephrology volume 1, pages 18–19 (2005)Cite this article

boxed-textFerramosca E et al. (2005) Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. Am Heart J 149: 820–825

Hemodialysis patients with mild to moderate hyperphosphatemia, hypercalcemia and hypercholesterolemia can benefit from the 'bonus effects' of sevelamer on lipids and inflammatory markers

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. US Renal Data System (2003) Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda: National Institutes of Health

  2. Nissen SE et al. (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291: 1071–1080

    Article  CAS  Google Scholar 

  3. Ridker PM et al. (2005) C-reactive protein levels and outcomes after statin therapy. New Engl J Med 352: 20–28

    Article  CAS  Google Scholar 

  4. Qunibi WY et al. (2004) Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study). Kidney Int 65: 1914–1926

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was writte by Chloe Harman Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. University of Texas Health Science Center at San Antonio, Texas, USA

    Wajeh Y Qunibi

  2. University of Texas Hospital,

    Wajeh Y Qunibi

Authors
  1. Wajeh Y Qunibi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wajeh Y Qunibi.

Ethics declarations

Competing interests

The author has received research grants and honoraria from Nabi Biopharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qunibi, W. Does sevelamer have anti-atherosclerotic properties in maintenance hemodialysis patients?. Nat Rev Nephrol 1, 18–19 (2005). https://doi.org/10.1038/ncpneph0017

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0017

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing